Ratings Integrated Research Limited

Equities

IRI

AU000000IRI3

Market Closed - Australian S.E. 02:10:05 2024-04-29 am EDT 5-day change 1st Jan Change
0.43 AUD +4.88% Intraday chart for Integrated Research Limited +22.86% +19.44%

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
  • The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

  • Thanks to a sound financial situation, the firm has significant leeway for investment.
  • The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
  • The company shows low valuation levels, with an enterprise value at 0.67 times its sales.
  • For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
  • For the past twelve months, EPS forecast has been revised upwards.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
  • Historically, the company has been releasing figures that are above expectations.

Weaknesses

  • The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
  • Revenue estimates are regularly revised downwards for the current and coming years.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Software

1st Jan change Capi. Investor Rating ESG Refinitiv
+19.44% 46.69M
C
+6.29% 3,020B
C+
+5.27% 82.93B
B
+2.99% 76.85B
B+
-15.18% 53.04B
B+
+31.62% 50.15B
D+
-26.04% 46.71B
B-
+16.55% 41.41B
D+
+57.68% 36.1B
D+
-10.64% 24.64B
C+
Investor Rating
Trading Rating
ESG Refinitiv

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
-
Price to Free Cash Flow
-
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. IRI Stock
  4. Ratings Integrated Research Limited